Clinical trials
Not yet recruiting Hematologic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
77 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 3 |
| 2023 | 2 |
| 2024 | 8 |
| 2025 | 14 |
| 2026 | 49 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 77 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 4 |
| Institute of Hematology & Blood Diseases Hospital, China | 4 |
| Nanfang Hospital, Southern Medical University | 3 |
| Institut Paoli-Calmettes | 2 |
| M.D. Anderson Cancer Center | 2 |
| Nanjing Miracle Biotechnology Co., Ltd. | 2 |
| The First Affiliated Hospital of Soochow University | 2 |
| University Hospital, Caen | 2 |
| Zhejiang University | 2 |
| Alexandria University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 77 |
| Lymphoma | 9 |
| Neoplasms | 9 |
| Recurrence | 6 |
| Leukemia | 5 |
| Multiple Myeloma | 5 |
| Hematologic Diseases | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 |
| Leukemia, Myeloid, Acute | 4 |
| Febrile Neutropenia | 3 |
Trials
Showing 51 to 75 of 77. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.